A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This is a study to determine the optimal treatment for patients with advanced stage or
recurrent endometrial cancer. Traditionally, patients have been treated with either hormonal
therapies (megesterol) or chemotherapy (paclitaxel and carboplatin). This study investigates
the effectiveness of the combination of hormonal therapy and chemotherapy. This study also
will examine the side-effects associated with these drugs and the quality of life of patients
on combination therapy.